{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "MOH",
  "name": "Molina Healthcare, Inc.",
  "url": "https://orbyd.app/dossiers/MOH/",
  "json_url": "https://orbyd.app/dossiers/MOH.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Medicaid-margin-trough recovery, now fully re-rated: June's Illinois-win + BofA-double-upgrade breakout to ~$230 has matured into target catch-up (July raises to $230-250, but ratings stayed neutral and Barclays cut to $184). The whole leg now hinges on a violent-history Q2 print 2026-07-22 — extended, and inside earnings blackout.",
  "invalidation_trigger": "A weekly close below $205 fills the late-June breakout gap and reverts MOH into its prior $188-192 chop, ending the momentum leg. Secondary: Q2 (2026-07-22) Medicaid MCR re-expanding above ~93%, or a FY26 adj-EPS guide cut below $5.00, signals the cost trend re-accelerating and breaks the trough thesis.",
  "catalyst_date": null,
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "managed-care-health-services"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "EARNINGS BLACKOUT: Q2 2026 confirmed 2026-07-22 after close, call 2026-07-23 8:00 ET — binary on Medicaid cost-trend control; no fresh entry within 3 trading days prior.",
    "July target-raise cluster ($230-250: RBC 07-09, Wells Fargo 07-13, TD Cowen 07-14, Truist 07-14) came with ratings HELD at Hold/EW/SP; Barclays cut to $184/Underweight 07-09. Targets caught up to price, ratings did not — late-stage validation, not a fresh accelerating signal.",
    "GAAP P/E is distorted by the $93M MA-PD exit charge; underwrite on adjusted EPS (≥$5.00 on the trough year), not GAAP.",
    "2026 is the explicitly-called Medicaid-margin trough year; sector underfunded ~300-400bps — the real upside is 2027-28 normalization, a multi-quarter fundamental hold, not a momentum sprint.",
    "ACA enhanced premium tax credits expired end-2025; Marketplace enrollment projected -25% (22.3M→~17.5M) into 2026 — structural headwind; any subsidy-extension legislation is a re-rate trigger.",
    "S&P index reconstitution (2026-07-16): MOH moving into the S&P MidCap 400 — a marker of cap erosion since the 2025 collapse and a modest forced-flow overhang landing near the print.",
    "Medicaid twice-a-year eligibility checks begin December 2026 (flagged 2026-07-16) — redetermination/attrition risk into 2027.",
    "MATURING, tipping toward SATURATED — stand aside for fresh entries until after the 2026-07-22 print; probe-only even then unless it re-accelerates on a managed-care sector-cluster breakout above the $230 target ceiling. Chop zone $188-192; first support/gap-fill $205-210."
  ],
  "body_markdown": "## Current Thesis\nJune's momentum leg — the 2026-06-10 Illinois HealthChoice Medicaid win plus BofA's ~2026-06-24 double-upgrade (Underperform→Buy, $152→$250) that broke MOH out of its $188–192 chop to a $229.74 close (2026-06-26) — has matured into a wait-for-the-print consolidation. Through July the rest of the sell-side raised targets into the price: RBC $248 (07-09), TD Cowen $230 (07-14), Truist $250 (07-14), Wells Fargo $235 (07-13). But every one of those raises kept a neutral rating (Hold/Equal-Weight/Sector-Perform), and Barclays cut its target to $184 while staying Underweight (07-09). The Medicaid-margin-trough recovery is intact, but it is now fully re-rated and sitting on a violent-history Q2 print (2026-07-22 after close). The read is a coiled pre-earnings range, not an entry zone: buying two trading days ahead of a binary this jumpy is a coin-flip on the tape, not on the thesis.\n\n## Bull Case\n- **BofA double-upgrade (~2026-06-24)** anchors the multi-year ramp: Underperform→Buy, PT $152→$250, EPS modeled to ~$30 by 2029 vs Street ~$17.32 — framing the $5 trough as the floor of an earnings normalization, \"more a matter of time and math.\"\n- **July target cluster validates the level**: even neutral-rated desks now peg fair value at $230–250 (RBC $248 07-09, Truist $250 07-14, Wells Fargo $235 07-13, TD Cowen $230 07-14). The June breakout is no longer a lone-analyst pop.\n- **Illinois HealthChoice award (2026-06-10)**: one of six plans across ~3.1M beneficiaries — a concrete retention/growth datapoint under the revenue base that fed the breakout.\n- **Q1 2026 stabilization (late Apr)**: adj EPS $2.35, consolidated MCR 91.1%, Medicaid MCR 92.0%, FY26 reaffirmed ~$42B premium revenue / ≥$5.00 adj EPS, with management calling medical-cost trend \"moderately favorable.\"\n- **2027 rate catch-up**: CMS lifted 2027 rates (flagged ~2026-04-23) against a sector underfunded ~300–400bps; 2026 is the called trough, 2027–28 the normalization. Investor Day (2026-05-08) set a $25 adj-EPS-by-2029 target.\n\n## Bear Case\n- **Targets caught up to price, ratings did not.** July's raises to $230–250 all held Hold/EW/SP — desks now underwrite the price but not more upside — while Barclays cut to $184/Underweight (07-09). A $184–250 dispersion is low conviction on direction, and PT-catch-up after a +20% run is late-cycle validation.\n- **Q2 print (2026-07-22) is a binary with brutal history.** Q4 2025 was an adjusted loss of -$2.75/sh and a guide-slash to ≥$5.00 from ~$13.71 consensus; the stock fell 28%. One quarter of \"moderately favorable\" trend (Q1's 92.0% Medicaid MCR still sits well above healthy high-80s) does not prove durable cost control into a high-bar number.\n- **Peer warning (2026-07-15)**: Elevance's outlook boost disappointed and the stock sank — evidence that managed-care cost trend is still pressured heading into MOH's own print.\n- **ACA pressure persists**: enhanced premium tax credits expired end-2025; WSJ (2026-07-08) reports insurers seeking big rate hikes again; Marketplace enrollment is projected 22.3M→~17.5M (-25%) into 2026, an adverse-selection headwind to Molina's Marketplace book.\n- **Redetermination overhang**: new twice-a-year Medicaid eligibility checks begin December 2026 (flagged 2026-07-16) — a membership-attrition catalyst into 2027.\n- **Index-flow overhang**: an S&P reconstitution (announced 2026-07-16) moves MOH into the S&P MidCap 400 — a marker that its ~$13B cap has fallen below the S&P 500 floor since the 2025 collapse, and a modest forced-selling cross-current from S&P 500 trackers landing near the print window.\n\n## Setup & Price Structure\n- Breakout structure: cleared the $188–192 chop through the $205–210 shelf to a $229.74 close (2026-06-26, +6.3% on the day), ~+20% in three weeks.\n- Now consolidating just under the $230–250 target ceiling and extended above the $188–192 base; the $205–210 shelf is the first support and the late-June gap-fill zone.\n- Momentum leg is spent for now — targets bracket spot, ratings are neutral, one desk is outright bearish. The tape reads as a coiled pre-earnings range rather than an accelerating trend.\n- Two overlapping cross-currents hit the same window: the 2026-07-22 print and the S&P MidCap 400 index rebalance.\n- No clean fresh entry exists inside three trading days of the print.\n\n## Catalyst Calendar (next 30 days)\n\n*No upcoming dated catalysts on file — the dated entries below have passed.*\n\n## Elapsed catalysts\n\n- **2026-07-22 (after close)** — Q2 2026 earnings: THE binary. Medicaid MCR trend and FY26 ≥$5.00 adj-EPS confirmation vs cut. *(passed 18d ago)*\n- **2026-07-23 8:00 ET** — Q2 earnings call. *(passed 17d ago)*\n- **~2026-07-16 → late July** — S&P MidCap 400 index change effective at the July rebalance; forced-flow window. *(passed 24d ago)*\n- **Ongoing** — ACA 2027 rate-filing headlines (WSJ 2026-07-08); any enhanced-subsidy-extension legislation is a re-rate trigger. *(passed 32d ago)*\n- **December 2026 (dated 2026-07-16, beyond 30d)** — Medicaid twice-a-year eligibility checks begin; redetermination attrition catalyst worth pre-positioning around. *(passed 24d ago)*\n\n## What Would Change Our Mind\n- Thesis-break level: a weekly close below $205 fills the late-June breakout gap and reverts MOH into the $188–192 chop, ending the momentum leg.\n- Fundamental break: Q2 Medicaid MCR re-expanding above ~93%, or a FY26 adj-EPS guide cut below $5.00 — either says the cost trend is re-accelerating and the trough thesis is broken.\n- Bull re-confirmation: a post-print hold above $210 with Medicaid MCR compressing toward the low-90s/high-80s and FY26 reaffirmed would re-open the recovery as a multi-quarter fundamental hold.\n- Theme confirmation: actual rating upgrades off Hold (not just target raises) would signal the narrative is still accelerating rather than saturating.\n\n## Correlation Notes\n- Managed-care cohort — CNC (Centene), ELV (Elevance), UNH, HUM: MOH trades with the group's Medicaid cost-trend read, and Elevance's 2026-07-15 disappointment is a direct negative peer signal into the print. BofA paired MOH with CNC as top 2027-margin-upside names.\n- Policy beta: the Medicaid rate cycle (CMS 2027 rates), ACA subsidy legislation, and redetermination timelines make MOH a high-beta expression of federal healthcare policy more than a company-specific story.\n- Index flow: the S&P 500 → MidCap 400 move (2026-07-16) is a technical, non-fundamental cross-current that muddies the post-print price signal.",
  "first_seen": "2026-04-30",
  "last_analyzed": "2026-07-18T08:20:35+00:00",
  "last_synthesized": "2026-07-18",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}